Biologic drugs may be more dangerous than previous thought; Merck trying to take over India vaccine market;

> Biologic drugs may not be as safe as doctors tend to think they are. A new study shows that one in four biological drugs end up being slapped with serious safety warnings within five years of release. FiercePharma

> Merck is already a major player in the pharmaceutical industry in the U.S., but they'd like to kick things up a notch in India. The pharmaceutical giant is looking to roll out vaccines concurrently in India instead of up to 20 years later, which would give them a huge share of the Indian vaccine market. FierceVaccines

> While the U.S. is still spending the most of any nation in the world on R&D, some countries who are further down on the list are closing the gap fast, including India and China. FierceBioResearcher

> Boston Consulting Group has done the math and found that Obama's health plan could cost big pharmaceutical companies anywhere from $10 billion to $30 billion by having the federal government renegotiate prices. FiercePharma

And Finally... I bet this couple didn't expect the topping they got on their taco! Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.